Non-invasive biomarkers for early detection of breast cancer

J Li, X Guan, Z Fan, LM Ching, Y Li, X Wang, WM Cao… - Cancers, 2020 - mdpi.com
Simple Summary Early diagnosis of breast cancer greatly increases the chance of cure and
survival from the disease. The mammogram is widely used for early detection of breast …

[HTML][HTML] Biosensors as diagnostic tools in clinical applications

C Lino, S Barrias, R Chaves, F Adega… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Nowadays, the development of new technological solutions in the medical field, in particular
biosensors, is a priority and a ground for great scientific and financial investment. From …

A review of biosensors for detecting tumor markers in breast cancer

R Hong, H Sun, D Li, W Yang, K Fan, C Liu, L Dong… - Life, 2022 - mdpi.com
Breast cancer has the highest cancer incidence rate in women. Early screening of breast
cancer can effectively improve the treatment effect of patients. However, the main diagnostic …

A dual-ratio fluorescent probe with a single excitation triple-signal to synchronously detect PTK7 and miRNA-21 for breast cancer early diagnosis

L Shi, J Li, Q Xiang, Y Tan, H Zhang, S Liu… - Biosensors and …, 2023 - Elsevier
The measurement of tumor biomarker levels is of great significance for early diagnosis of
breast cancer. The combination diagnosis of multiple tumor biomarkers will significantly …

Recent discoveries of macromolecule-and cell-based biomarkers and therapeutic implications in breast cancer

HJ Wu, PY Chu - International Journal of Molecular Sciences, 2021 - mdpi.com
Breast cancer is the most commonly diagnosed cancer type and the leading cause of cancer-
related mortality in women worldwide. Breast cancer is fairly heterogeneous and reveals six …

Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer

R An, H Yu, Y Wang, J Lu, Y Gao, X Xie, J Zhang - Cancer & Metabolism, 2022 - Springer
Background Breast cancer (BC) is the most commonly diagnosed cancer. Currently,
mammography and breast ultrasonography are the main clinical screening methods for BC …

Prognostic and diagnostic values of non-coding RNAs as biomarkers for breast cancer: An umbrella review and pan-cancer analysis

A Bahramy, N Zafari, F Rajabi, A Aghakhani… - Frontiers in Molecular …, 2023 - frontiersin.org
Background: Breast cancer (BC) is the most common cancer in women. The incidence and
morbidity of BC are expected to rise rapidly. The stage at which BC is diagnosed has a …

Vaccines in breast cancer: challenges and breakthroughs

GN Fatima, H Fatma, SK Saraf - Diagnostics, 2023 - mdpi.com
Breast cancer is a problem for women's health globally. Early detection techniques come in
a variety of forms ranging from local to systemic and from non-invasive to invasive. The …

The role of TPS, CA125, CA15-3 and CEA in prediction of distant metastasis of breast cancer

J Zhang, Q Wei, D Dong, L Ren - Clinica Chimica Acta, 2021 - Elsevier
Objective To explore the application value of breast cancer tumor markers tissue
polypeptide specific antigen (TPS), carbohydrate antigen 15-3 (CA15-3), carcinoembryonic …

Identification of long noncoding RNAs as predictors of survival in triple‐negative breast cancer based on network analysis

XX Li, LJ Wang, J Hou, HY Liu, R Wang… - BioMed research …, 2020 - Wiley Online Library
Breast cancer is the most common cancer observed in adult females, worldwide. Due to the
heterogeneity and varied molecular subtypes of breast cancer, the molecular mechanisms …